
Researchers at Colorado State University are helping to develop an experimental Ebola vaccine for use by the military.
The university's BioMARC lab, a high-containment biopharmaceutical facility, will produce a small amount of the vaccine for the Defense Department. Military researchers will test the vaccine in a small human trial.
BioMARC was awarded the subcontract from the Department of Defense's Medical Countermeasures Systems Joint Vaccine Acquisition program. The program has previously worked to develop and synthesize vaccines protecting soldiers (and later civilians) against anthrax and smallpox.
"BioMARC will make contributions towards furthering the development of a replicon vaccine platform containing a non-infection Ebola antigen, which has been show to protect nonhuman primates from an intramuscular and aerosol challenge with the Ebola virus," officials at Colorado State said in a statement.
"We welcome the opportunity to assist in a project that is of such great significance to protecting human health," Dennis Pierro, BioMARC's director and a professor at Colorado State University, added.
The lab will also synthesize a small production of an experimental Marburg vaccine. Marburg is another deadly disease found in Africa.
"Colorado State has long been on the front lines of fighting infectious diseases in humans and animals -- from retroviruses to vector-borne viral diseases," school president Tony Frank said. "We're proud now to be able to put our resources and expertise to work in the pressing fight against Ebola."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor